Patent Yard Sign in
Canadian application, no grantCanada

New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias

CA 2394097 A1 · Owner: Bjorsne, Magnus · Inventors: Svensson, Peder; Ponten, Fritiof; Strandlund, Gert

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

There is provided compounds of formula (I) wherein R1, R2, R3 and Ra to Rh , have meanings given in the description which are useful in the prophylaxis , and in the treatment of arrhythmias in particular atrial and ventricular , arrhythmias a process for the preparation of compounds of formula (I) and , intermediate compounds.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 19, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 19, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 19, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 19, 2000
GrantedNo grant recorded
Term endedDecember 19, 2020
Patent numberCA 2394097 A1
Classification (IPC)C07D221/24 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedDec 19, 2000Term endedDec 19, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.